EUVIMEDEUVIMED entdecken
Crossref

Nicotinic Acetylcholine Receptor Subunit Alpha-7 Mediates PD-L1 and CTLA-4 Expression in HepG2 Cells

Mina Afrashteh Nour, Fatemeh Kheradmand, Yousef Rasmi, Zahra Asadzadeh, Mohammad Amin Doustvandi, Mahdi Jafarlou, Khalil Hajiasgharzadeh, Behzad Baradaran

ImmunoAnalysis · 2021

DOI: 10.34172/ia.2021.10 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ImmunoAnalysis, 2021. Verfasst von Mina Afrashteh Nour und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The liver is the largest solid organ in the body and has several unique immunological roles. The alpha7 subtype of nicotinic acetylcholine receptor (α7nAChR) is expressed in the liver and has different immunoregulatory effects. Programmed death ligand 1 (PD-L1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) are two major checkpoints that act as a negative regulator of the immune system. In this study, we examined the effects of activation (with nicotine) and inhibition (with specific siRNA) of α7nAChR on the PD-L1 and CTLA-4 genes expression.

Methods

Human hepatocellular carcinoma (HepG2) cell line was used to investigate the effects of treatment with low dose (1 μM) and high dose (10 μM) of nicotine on the PD-L1 and CTLA-4 expression. In addition to this, the effects of treatment with 100 nM concentration of specific siRNA targeting α7nAChR (α7-siRNA) were examined using quantitative real-time PCR.

Results

Compared to untreated cells, the HepG2 cells treated with nicotine exhibited significant dose-dependent decreases in PD-L1 expression. Furthermore, nicotine has a biphasic effect on the CTLA-4 expression and decreased its expression in 10 μM concentration. The qRT-PCR revealed that α7-siRNA significantly reduced the mRNA levels of α7nAChR (P < 0.01). Also, compared to control cells, α7-siRNA treated cells exhibited significant increases in both PD-L1 and CTLA-4 expression.

Conclusion

These experiments determined that nicotine treatment leads to decreases in PD-L1 and CTLA-4 expression. These effects are reversed by treatment with α7-siRNA, which indicates the involvement of α7nAChR related mechanisms in these processes.

Zitieren

APA

Nour, M. A., Kheradmand, F., Rasmi, Y., Asadzadeh, Z., Doustvandi, M. A., Jafarlou, M., Hajiasgharzadeh, K., & Baradaran, B. (2021). Nicotinic Acetylcholine Receptor Subunit Alpha-7 Mediates PD-L1 and CTLA-4 Expression in HepG2 Cells. ImmunoAnalysis. https://doi.org/10.34172/ia.2021.10

Vancouver

Nour MA, Kheradmand F, Rasmi Y, Asadzadeh Z, Doustvandi MA, Jafarlou M, et al. Nicotinic Acetylcholine Receptor Subunit Alpha-7 Mediates PD-L1 and CTLA-4 Expression in HepG2 Cells. ImmunoAnalysis. 2021. doi:10.34172/ia.2021.10

BibTeX
@article{Nour2021,
  author = {Nour, Mina Afrashteh and Kheradmand, Fatemeh and Rasmi, Yousef and Asadzadeh, Zahra and Doustvandi, Mohammad Amin and Jafarlou, Mahdi and Hajiasgharzadeh, Khalil and Baradaran, Behzad},
  title = {Nicotinic Acetylcholine Receptor Subunit Alpha-7 Mediates PD-L1 and CTLA-4 Expression in HepG2 Cells},
  journal = {ImmunoAnalysis},
  year = {2021},
  doi = {10.34172/ia.2021.10}
}
Kostenlos starten →